Market Research Logo

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2017

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2017

In the last several years, global market of drugs for herpes labialis (oral herpes) developed smoothly, with an average growth rate of 4.9%. In 2016, global consumption value of drugs for herpes labialis (oral herpes) is nearly 2000 M USD.

This report studies Drugs for Herpes Labialis (Oral Herpes) in Global market, especially in North America, Europe, China, Rest of Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Drugs for Herpes Labialis (Oral Herpes) in these regions, from 2012 to 2022 (forecast), like
North America
Europe
China
Rest of Asia
Latin America
Middle East and Africa

Split by Product Types, with revenue market share and growth rate of each type, can be divided into
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other

Split by applications, this report focuses on revenue market share and growth rate of Drugs for Herpes Labialis (Oral Herpes) in each application, can be divided into
External Use
Oral
Injection


1 Drugs for Herpes Labialis (Oral Herpes) Market Overview
1.1 Product Overview and Scope of Drugs for Herpes Labialis (Oral Herpes)
1.1.1 Definition of Drugs for Herpes Labialis (Oral Herpes)
1.1.2 Specifications of Drugs for Herpes Labialis (Oral Herpes)
1.2 Drugs for Herpes Labialis (Oral Herpes) Segment by Types and Drugs Types
1.2.1 Global Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Types
1.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (%) Comparison by Drug Type (2012-2022)
1.3 Drugs for Herpes Labialis (Oral Herpes) Segment by Applications
1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Comparison by Applications (2012-2022)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Drugs for Herpes Labialis (Oral Herpes) Market by Regions
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth (%) Comparison by Regions
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Europe Status and Prospect (2012-2022)
1.4.5 Rest of Asia Status and Prospect (2012-2022)
1.4.6 Latin America Status and Prospect (2012-2022)
1.4.7 Middle East and Africa Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Drugs for Herpes Labialis (Oral Herpes) (2012-2022)
2 Global Drugs for Herpes Labialis (Oral Herpes) Market Competition by Manufacturers
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Share by Manufacturers (2016 and 2017)
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Share by Manufacturers (2016 and 2017)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Gross Margin of Manufacturers (2016 and 2017)
2.4 Manufacturers Drugs for Herpes Labialis (Oral Herpes) Headquarters, Sales Area
2.5 Drugs for Herpes Labialis (Oral Herpes) Market Competitive Situation and Trends
2.5.1 Drugs for Herpes Labialis (Oral Herpes) Market Concentration Rate
2.5.2 Drugs for Herpes Labialis (Oral Herpes) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) by Regions (2012-2017)
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Market Share by Regions (2012-2017)
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Regions (2012-2017)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.4 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.5 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.6 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.7 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.8 Latin America Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
3.9 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin Trend by Type
4.1 By Product Catalog
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Product Catalog (2012-2017)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share (%) by Product Catalog (2012-2017)
4.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Gross Margin by Type (2012-2017)
4.2 By Drug Type
4.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Drug Type (2012-2017)
4.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share (%) by Drug Type (2012-2017)
4.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Gross Margin by Type (2012-2017)
5 Global Drugs for Herpes Labialis (Oral Herpes) Market Analysis by Applications
5.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications (2012-2017)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (%) by Applications (2012-2017)
6 Analysis of Drugs for Herpes Labialis (Oral Herpes) Industry Key Manufacturers
6.1 GSK
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Revenue, Cost, Gross, and Gross Margin
6.2 Novartis
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Revenue, Cost, Gross, and Gross Margin
6.3 Teva
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Revenue, Cost, Gross, and Gross Margin
6.4 Mylan
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Revenue, Cost, Gross, and Gross Margin
6.5 Cadila
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Revenue, Cost, Gross, and Gross Margin
6.6 Apotex
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Revenue, Cost, Gross, and Gross Margin
6.7 Daewoong
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Revenue, Cost, Gross, and Gross Margin
6.8 Livzon
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Revenue, Cost, Gross, and Gross Margin
6.9 Luoxin
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Revenue, Cost, Gross, and Gross Margin
6.10 Med shine
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Revenue, Cost, Gross, and Gross Margin
6.11 Bayer (Campho Phenique)
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Revenue, Cost, Gross, and Gross Margin
6.12 Blistex
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Revenue, Cost, Gross, and Gross Margin
6.13 Kelun Group
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Revenue, Cost, Gross, and Gross Margin
6.14 Hikma
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Revenue, Cost, Gross, and Gross Margin
6.15 Haiwang
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Revenue, Cost, Gross, and Gross Margin
6.16 Carmex
6.16.1 Company Profile
6.16.2 Product Information
6.16.3 Revenue, Cost, Gross, and Gross Margin
6.17 Cipher
6.17.1 Company Profile
6.17.2 Product Information
6.17.3 Revenue, Cost, Gross, and Gross Margin
7 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Cost Analysis
7.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials and Manufacturing Equipment Analysis
7.1.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials Analysis
7.1.2 Raw Materials Sources of Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers
7.1.3 Drugs for Herpes Labialis (Oral Herpes) Key Manufacturing Equipment Analysis
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.2.4 Other Costs Analysis
7.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Market Drivers
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
11.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Regions (2017-2022)
11.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) and Revenue Forecast (2017-2022)
11.2.3 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.2.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.2.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.2.6 China Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast (2017-2022)
11.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2017-2022)
11.3.1 by Product Catalog
11.3.2 by Drug Type
11.4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Picture of Drugs for Herpes Labialis (Oral Herpes)
Table Specifications of Drugs for Herpes Labialis (Oral Herpes)
Table Classification of Drugs for Herpes Labialis (Oral Herpes)
Figure Global Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Types in 2016
Figure Product Picture of Valacyclovir
Figure Product Picture of Aciclovir
Figure Product Picture of Famciclovir
Figure Docosanol Picture
Table Classification Comparison of Different Types of Drugs for Herpes Labialis (Oral Herpes)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share (%) by Drug Type in 2016
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) Comparison by Applications (2012-2022)
Figure Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Applications in 2016
Figure External Use Examples
Figure Oral Examples
Figure Injection Examples
Table Global Market Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) Comparison by Regions 2012-2022
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure Latin America Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Growth Rate (2012-2022)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2016 and 2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers (2016 and 2017)
Figure 2016 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers
Figure 2017 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) of Key Manufacturers (2016 and 2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers (2016 and 2017)
Figure 2016 Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers
Figure 2017 Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers
Table Global Market Drugs for Herpes Labialis (Oral Herpes) Gross Margin of Key Manufacturers (2016 and 2017)
Figure Global Market Drugs for Herpes Labialis (Oral Herpes) Gross Margin of Key Manufacturers in 2016
Figure Global Market Drugs for Herpes Labialis (Oral Herpes) Gross Margin of Key Manufacturers in 2017
Table Manufacturers Drugs for Herpes Labialis (Oral Herpes) Headquarters and Sales Area
Figure Drugs for Herpes Labialis (Oral Herpes) Revenue Market Concentration Rate in 2016
Figure Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share of Top 3 Manufacturers in 2016
Figure Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share of Top 5 Manufacturers in 2016
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Regions (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions (2012-2017)
Figure 2012-2017 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions
Table 2016 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) by Regions (2012-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Regions (2012-2017)
Figure 2012-2017 Global Drugs for Herpes Labialis (Oral Herpes) Gross Market Share by Regions
Table 2016 Global Drugs for Herpes Labialis (Oral Herpes) Gross Market Share by Regions
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table China Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table Latin America Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Product Catalog (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share (%) by Product Catalog (2012-2017)
Figure Revenue Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Product Catalog (2012-2017)
Figure 2016 Revenue Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Product Catalog
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) by Product Catalog (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share (%) by Product Catalog (2012-2017)
Figure Gross Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Product Catalog (2012-2017)
Figure 2016 Gross Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Product Catalog
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Margin by Product Catalog (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Drug Type (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share (%) by Drug Type (2012-2017)
Figure Revenue Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Drug Type (2012-2017)
Figure 2016 Revenue Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Drug Type
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) by Drug Type (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share (%) by Drug Type (2012-2017)
Figure Gross Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Drug Type (2012-2017)
Figure 2016 Gross Market Share (%) of Drugs for Herpes Labialis (Oral Herpes) by Drug Type
Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Margin by Drug Type (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Applications (2012-2017)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share (%) by Applications (2012-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share (%) by Applications (2012-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share (%) by Applications in 2016
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (%) by Applications (2012-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate (%) by Applications (2012-2017)
Table GSK Company Profile
Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of GSK
Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of GSK
Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of GSK 2016-2017
Table Novartis Company Profile
Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Novartis
Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Novartis 2016-2017
Table Teva Company Profile
Table Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Teva
Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Teva 2016-2017
Table Mylan Company Profile
Table Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Mylan
Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Mylan 2016-2017
Table Cadila Company Profile
Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Cadila 63

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report